The Iliac/SFA/Popliteal Center

Filter Your Results

 

News

 

New Appropriate Use Criteria Address Peripheral Artery Interventions

January 16, 2019 -- The American College of Cardiology (ACC) announced that the "2018 Appropriate Use Criteria for Peripheral Artery Intervention" document was publi…

Atherectomy Included in Pivotal Study of QT Vascular's Chocolate Touch DCB

January 16, 2019 -- QT Vascular Ltd. announced that the FDA has granted approval to include the use of atherectomy for lesion preparation in its ongoing United States pivotal …

CSI Announces First Treatments in United States With OrbusNeich Teleport Microcatheter

January 9, 2019 -- Cardiovascular Systems, Inc. (CSI) announced that the first patients in the United States were treated using the OrbusNeich Teleport microcatheter, which re…

Intact Vascular Completes Enrollment for TOBA II BTK Trial

January 3, 2019 -- Intact Vascular, Inc. announced that it has completed enrollment ahead of schedule for its TOBA II BTK clinical trial. TOBA II BTK is a single-arm prospe…

VIVA Physicians' Vascular Leaders Forum on Drug-Eluting Devices in PAD Scheduled

December 19, 2018 -- VIVA Physicians announced details for a special session of its Vascular Leaders Forum. The goal of the forum is to analyze a recent meta-analysis that ass…

BD's Lutonix 018 DCB Approved by FDA to Treat SFA Disease

December 18, 2018 -- BD (Becton, Dickinson and Company) announced that it has received FDA approval for its 0.018-inch -- guidewire-compatible Lutonix 018 drug-coated balloon …

VIVA Physicians to Hold Forum on Drug Elution in Peripheral Artery Disease

December 14, 2018 -- With the recent concerns centered around drug-eluting devices and peripheral arterial disease, VIVA Physicians, a 501(c)3 not-for-profit organization dedi…

Recruitment in BASIL-3 Trial Paused After Report of 5-Year Mortality Risk With DCB/DES in SFA

December 13, 2018 -- Recruitment has been paused in the BASIL-3 clinical trial, according to an announcement from the Birmingham Clinical Trials Unit (BCTU) at the University …

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.